EN
HI
Summary
As of 31 Aug, 2026, Glenmark Pharmaceuticals stock price is ₹2524.5. During the trading session, the stock has moved between an intraday low of ₹2523.00 and an intraday high of ₹2532.40. Over the last 52 weeks, Glenmark Pharmaceuticals has traded between ₹1792.60 and ₹2537.60.
The stock has recorded a trading volume of 10,520 shares, with a market capitalization of ₹282200809. Its Average Traded Price (ATP) is ₹2528.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 6 @ ₹2524.50.
Glenmark Pharmaceuticals has an upper circuit limit of ₹2763.70 and a lower circuit limit of ₹2261.30. The total value traded stands at ₹2.66 CR, and the delivery percentage for the day is 48.92%.
The stock is currently traded with a market lot size of 1. Glenmark Pharmaceuticals also offers a dividend yield of 0.1%.
Glenmark Pharmaceuticals share price chart
Glenmark Pharmaceuticals Share Key Metrics
Volume
10520.00
Market Cap
70973.50 CR
LTQ@LTP
6@2524.50
ATP
2528
Var Margin
15.14 %
Circuit Range
2261.3-2763.7
Delivery %
48.92 %
Value
2.66 CR
ASM/GSM
No
Market Lot
1
Glenmark Pharmaceuticals Fundamentals
P/E Ratio
39.52
P/B Ratio
6.48
Div. Yield
0.1
Sector P/E
69.42
Sector P/B
3.5
Sec. Div. Yield
0.51
Glenmark Pharmaceuticals Resistance and Support
Pivot 2494.77
Resistance
First Resistance
2557.84
Second Resistance
2600.67
Third Resistance
2663.74
Support
First Support
2451.94
Second Support
2388.87
Third Support
2346.04
Glenmark Pharmaceuticals Futures & Options
Glenmark Pharmaceuticals Option Chain
View Price, OI, Greeks & More...
29SEP26
2536.00
3.40 (0.13%)
27OCT26
2536.00
-8.60 (0.34%)
23NOV26
2551.50
0.00 (0.00%)
GLENMARK|29SEP26 CE 2520.00
74.65
1.2 (1.63%)
GLENMARK|29SEP26 PE 2540.00
72.1
1 (1.41%)
Glenmark Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Aug 31 2026 | 2532.4 | 2524.5 | 0.38% | 2532.4 | 2523 |
| Fri Aug 28 2026 | 2460 | 2515 | 2.24% | 2537.6 | 2431.69 |
| Thu Aug 27 2026 | 2455 | 2460 | 0.89% | 2484 | 2440.6 |
Glenmark Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-01-30 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-26 | Interim Dividend |
| 2025-08-14 | Quarterly Results |
| 2025-05-23 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Glenmark Pharmaceuticals News
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals Inc., USA launched Calcium Gluconate Injection USP, expanding its US injectables business and hospital portfolio. The market for this product has annual sales of approximately $69.9 million.
Aug 21 2026 08:52:23
Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharmaceuticals received US FDA approval for its Fluticasone Propionate Nasal Spray 0.05 mg/spray. This expands its respiratory portfolio in the U.S. and builds on its strong foundation in the therapeutic area.
Aug 20 2026 08:53:21
Read More
Glenmark Pharmaceuticals Management
| Name | Position |
|---|---|
| Rashmi Khandelwal | Company Secretary & Compliance Officer |
| Glenn Saldanha | Chairman & Managing Director |
Glenmark Pharmaceuticals Similar Stocks
Lupin Ltd.
2164.30
-7.20 (0.33%)
Mankind Pharma Ltd.
2384.00
1.10 (0.05%)
Max Healthcare Institute Ltd.
1011.40
-2.70 (0.27%)
Dr. Reddy's Laboratories Ltd.
1170.80
-7.20 (0.61%)
Aurobindo Pharma Ltd.
1648.30
3.00 (0.18%)
Fortis Healthcare Ltd.
922.20
-4.55 (0.49%)
Biocon Ltd.
410.55
-0.55 (0.13%)
Aster DM Quality Care Ltd.
751.40
3.00 (0.40%)
Alkem Laboratories Ltd.
5343.00
-12.00 (0.22%)
Abbott India Ltd.
26270.00
95.00 (0.36%)
Glenmark Pharmaceuticals FAQs
The Buying Price of Glenmark Pharmaceuticals share is 2524.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glenmark Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glenmark Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glenmark Pharmaceuticals shares is 39.52. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glenmark Pharmaceuticals shares is 6.48. Useful to assess the stock's value relative to its book value.
To assess Glenmark Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.42 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glenmark Pharmaceuticals is 70973.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glenmark Pharmaceuticals share price is 2537.60 & 1792.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glenmark Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
